In physiological compartments, provided with suitable reducing agents, transition metals are able to catalyze the activation of O 2 to various reactive oxygen species (ROS) 1 which readily attack biomolecules. The metal-catalyzed oxidation (MCO) of proteins plays an important role during oxidative stress and aging where modified proteins may accumulate in tissue (1-9). In addition, MCO also presents a stability problem for the biotechnological manufacturing of proteins (10, 11).
In physiological compartments, provided with suitable reducing agents, transition metals are able to catalyze the activation of O 2 to various reactive oxygen species (ROS) 1 which readily attack biomolecules. The metal-catalyzed oxidation (MCO) of proteins plays an important role during oxidative stress and aging where modified proteins may accumulate in tissue (1) (2) (3) (4) (5) (6) (7) (8) (9) . In addition, MCO also presents a stability problem for the biotechnological manufacturing of proteins (10, 11) .
A unique feature often observed during MCO of proteins is that only a few amino acid residues within a certain domain of the given protein are modified (2, 12) . Such site specificity is attributed to the generation of ROS at specific metal-binding sites, where the highly reactive ROS attack labile functional groups nearby rather than diffuse into the bulk medium. It has been shown that most of the enzymes labile to MCO require metals for activity (13) . The oxidation of these enzymes is less sensitive to the inhibition by exogenous ROS scavengers than would be expected on the basis of known rate constants for the reactions of specific ROS with these scavengers. However, one problem associated with all these studies is that neither the oxidizing species nor the intermediary protein-transition metal complexes formed during MCO of proteins have been well characterized. This is most pertinent to copper-catalyzed oxidation (i.e. to the frequently used ascorbate/Cu(II)/O 2 system) involving the Cu(II)/Cu(I) redox couple (2) . Here, Cu(II) will most probably require a different geometry and different ligands within the protein ligand sphere than Cu(I). An initial reduction of Cu(II), bound to a metal-binding site, to Cu(I) may change the geometry of the protein-metal complex, and possibly even release Cu(I) from the metal-binding site. On the other hand, the metal may be retained when (i) the protein is flexible enough to adapt to the new geometrical requirements of the reduced metal, or (ii) re-oxidation of the metal by molecular oxygen or reduction products of molecular oxygen such as superoxide or hydrogen peroxide occurs faster than the release of the reduced metal from the metal-binding site.
In a recent example for electron transfer coupled ligand dynamics in the model complex Cu(I/II)(TTCN) 2 , we could show that oxidation of tetrahedral [Cu(I)(TTCN) 2 ] ϩ potentially led to the loss of a ligand to yield [Cu(II)(TTCN)(H 2 O) 3 ] 2ϩ before geometrical reorganization around the Cu(II) atom allowed the addition of TTCN to give the final product, octahedral [Cu(II)(TTCN) 2 ] 2ϩ . 2 Analogous mechanisms may lead to kinetic complexities during protein oxidation which may be reflected in oxidation yields and kinetics as well as the nature of the oxidation products.
One amino acid particularly affected by MCO is histidine (His) (15) (16) (17) . There is as yet no detailed mechanism available for His oxidation in proteins, except a crystallographic study which showed the feasibility of metal-catalyzed processes within the metal-binding domain of glutamine synthetase (18) . However, such mechanisms and reaction stoichiometries are important to recognize, particularly in light of the fact that His oxidation products such as 2-oxo-His have been proposed as general markers for oxidative stress in vivo (19) .
In this work, we report a detailed mechanistic investigation of the ascorbate/Cu(II)/O 2 -induced oxidation of His in a selected model protein, human growth hormone (hGH), with the particular objective to identify the nature of the oxidizing species and the structural requirements for MCO of hGH. Ascorbate/ Cu(II)/O 2 has not only been used extensively as a non-enzymatic model oxidizing system but is of physiological relevance to conditions of oxidative stress. hGH was chosen because of its well characterized metal-binding site which shows high affinity for divalent metal ions, such as Zn(II) and Co(II) (20) . This site consists of His 18 and His 21 from helix I, and Glu 174 from helix IV. The primary sequence of hGH is displayed in Fig. 1 (21) .
EXPERIMENTAL PROCEDURES
Materials-Recombinant hGH (lyophilized form) and its synthetic tryptic fragment T3 (Ala-His-Arg) were provided by Genentech, Inc. (South San Francisco, CA). The protein was exchanged into a desired buffer by ultrafiltration using Microcon-10 microconcentrators from Amicon, Inc. (Beverly, MA). Typically 10 mg of hGH were dissolved in 500 l of 20 mM phosphate buffer, pH 7.4, the solution transferred into the microconcentrator and centrifuged for 20 min at 12,000 rpm in a tabletop centrifuge. Subsequently, the protein was washed three times with 250 l of 20 mM phosphate buffer, pH 7.4. The protein was finally taken up in a total volume of 4.5 ml of 20 mM phosphate buffer, pH 7.4, and the concentration of hGH in the stock solution determined by UV absorption at 277 nm where A 277 0.1% ϭ 0.82 cm Ϫ1 (22) , [MW hGH ϭ 22,125] (21). The Met 14 sulfoxide derivative T2ox of the tryptic fragment T2 was obtained synthetically: first, an amount of about 1.5 nmol of authentic T2 was obtained by tryptic digestion of hGH (conditions see below), purification by reversed-phase HPLC (conditions see below), and lyophilization. The fragment was redissolved in 100 l of neutral water and reacted for 12 h with 10 mM hydrogen peroxide. The only product of this reaction was T2ox which was purified by reversed-phase HPLC and characterized by MALDI-TOF mass spectrometry. Sequencing grade trypsin was obtained from Promega (Madison, WI); 1-propanol-d 7 (CD 3 CD 2 CD 2 OH) and 18 O-labeled water (95-98% atom pure 18 O) were from Cambridge Isotope Laboratories, Inc. (Andover, MA). All other reagents were of the highest grade commercially available.
Reaction Conditions-Unless specified otherwise, the oxidation of hGH by the ascorbate/Cu(II)/O 2 system was carried out under the following conditions (referred to as "standard conditions"): 200-l solutions containing 18 M hGH, 10 M CuCl 2 , 100 M ascorbate, and 10 mM sodium phosphate buffer, pH 7.4, were incubated at 25°C in 2-ml vials. In this way sufficient oxygen was available in the headspace of the vial to replenish oxygen in the reaction solution consumed through the oxidation of ascorbate. The reagents were sequentially added in the following order: water, hGH (in phosphate buffer), CuCl 2 , and ascorbate. The reaction was started by the addition of ascorbate, although switching the order of CuCl 2 and ascorbate did not affect the reaction kinetics or final yields (data not shown). All solutions were made with doubly distilled deionized water. The phosphate buffer stock solution was treated with Chelex 100 resin (Bio-Rad; 5 g/100 ml) to minimize metal contamination. Stock solutions of CuCl 2 and ascorbate were freshly prepared prior to the reactions.
Atmospheric oxygen was excluded in some reactions. Since purging inert gas through the protein-containing solutions and even freezethaw cycles would cause foaming and denaturation of the protein, a special piece of glassware was designed to saturate the protein reaction mixture with N 2 . The glassware of an H-shape was made of two small top-end-open glass tubes joined in the middle. The reaction mixture was placed in one side of the device and H 2 O in the other (solution surfaces below the joint). The two openings were then fitted with rubber septa, and two hypodermic needles were used as the N 2 gas inlet (needle immersed in H 2 O) and outlet (needle above the reaction solution), respectively. Before the inlet, N 2 gas was purified from residual oxygen contamination by an OxiClear disposable gas purifier (LabClear, Oakland, CA). This whole setting enabled the efficient removal of O 2 without protein denaturation or solvent evaporation. Other reagents, purged with N 2 separately, were added through the rubber septa using a gas tight syringe.
Tryptic digestion of hGH samples was performed at an initial dose of trypsin: hGH ϭ 1:50 (w/w) in 10 mM phosphate buffer, pH 7.4, at 37°C. A second equivalent dose was added after 2 h, and the samples were incubated for another 4 h. The digest was then quenched by cooling to 4°C.
Chromatographic Analysis-Intact hGH was monitored by weak anion exchange chromatography (AXC), reversed-phase HPLC (RP-HPLC), and size exclusion chromatography with UV detection at 214, 230, or 278 nm. Tryptic maps were analyzed by RP-HPLC and cation exchange chromatography (CXC). Table I summarizes the detailed information for the employed modes of chromatography.
The quantitative analysis of ascorbate was performed by capillary electrophoresis equipped with an electrochemical detector. The capillary electrophoresis system employed a 50 m x 70-cm fused silica capillary (Polymicrotechnologies; Phoenix, AZ), operating at 30 kV and 0.5 nA with 10 mM MES, pH 5.5, buffer as the mobile phase. The power supply was from Spellman High Voltage Corp. (Plainview, NY), and electrochemical detection was accomplished with an amperometric detector (model LC-4B; Bioanalytical Systems; West Lafayette, IN) employing a 33-m carbon fiber electrode operating at 800 mV (versus Ag/AgCl). Prior to capillary electrophoresis with electrochemical detection analysis, the reaction samples were quenched by EDTA and filtered by Microcon-10 micro-concentrators to remove protein components.
NMR Analysis-The 500 MHz 1 H NMR spectra were recorded on a Bruker AM-500 instrument. Typically 5 mg of hGH were exchanged into 400 -800 l of 10 mM sodium phosphate buffer in D 2 O, pD 7.4, by ultrafiltration using Microcon-10 microconcentrators (see "Materials") (the introduction of protons by 10 mM sodium phosphate into D 2 O can be considered negligible). When 1-propanol-d 7 was used as a co-solvent (40%, v/v), it was added after the ultrafiltration. Before the addition of 1-propanol-d 7 , the pD was measured to be 7.4. The final concentrations of hGH in all NMR samples were 0.2-0.4 mM. The samples were then kept overnight at room temperature to ensure the exchange of amide protons with D 2 O before NMR analysis.
Mass Spectrometry-Molecular weights of the purified tryptic fragments of hGH were analyzed by electrospray ionization (ESI) and/or matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS). ESI-MS experiments were performed on an Autospec-Q tandem hybrid mass spectrometer (VG Analytical Ltd., Manchester, United Kingdom) equipped with an OPUS data system. MALDI-TOF mass spectra were obtained on a Hewlett Packard model (20) , shown in bold letters.
G2025A which exhibited an accuracy of typically Ϯ 1 atomic mass unit for peptides with molecular masses below 3 kDa. The matrices for MALDI-TOF measurements (supplied by Hewlett Packard, Atlanta, GA) were 3,5-dimethoxy-4-hydroxycinnamic acid for peptides of mass Ͼ1 kDa and ␣-cyano-4-hydroxycinnamic acid for peptides of mass Ͻ1 kDa.
Fluorescence and Circular Dichroism Spectroscopy-A Shimadzu spectrofluorometer (RF 5000U) was used to monitor the fluorescent behavior of the tryptophan residue after the oxidative modification of hGH (standard conditions). The excitation wavelength was set at 298 nm, and the emission spectrum was recorded between 310 and 400 nm. The presence of dityrosine, one potential oxidation product of tyrosine, was also examined by fluorescence spectroscopy with an excitation wavelength at 325 nm and emission spectra recorded between 400 and 500 nm (23) . Circular dichroism (CD) measurements of hGH were performed on an AVIV model 60 DS spectrometer (Lakewood, NJ) essentially according to a published procedure (21) .
Amino Acid Analysis-For the preparation of oxidized hGH for amino acid analysis, hGH (19 M) was oxidized in 1 ml of solution (standard conditions). After a reaction time of 100 min, 100 l of 0.1 mM EDTA were added, maintaining pH 7.4. The solution was divided into two aliquots of 550 l, both of which were concentrated by centrifugation in a Microcon-10 microconcentrator and washed twice with 250 l of 20 mM sodium phosphate buffer, pH 7.4. Both protein samples were then redissolved into 250 l of 20 mM sodium phosphate buffer, pH 7.4, and two 100-l aliquots of each sample lyophilized in small vials.
Assuming an approximately 30% loss of material as a result of centrifugation in the microconcentrators, each aliquot contains about 3.3 nmol of protein. The protein samples were hydrolyzed with 6 M HCl at 110°C for 20 h. Subsequent amino acid analysis was performed by Commonwealth Biotechnologies, Inc., Richmond, VA.
RESULTS

Product Characterization for the Oxidation of hGH by Ascorbate/Cu(II)/O 2
Chemical Characterization-During the oxidation of 18 M hGH by 10 M CuCl 2 and 100 M ascorbate in air saturated 10 mM phosphate buffer at pH 7.4, AXC, pH 5.8, but not RP-HPLC revealed the rapid degradation of the hGH main peak paralleled by the appearance of two new more acidic peaks, implying the modification of some basic amino acid residues. Fig. 2 superimposes representative AXC chromatograms recorded immediately after the start (2 min) and at the end of a reaction (i.e. after complete consumption of ascorbate). The two major product peaks are indicated as peak 1 and peak 2. Each peak may contain more than one degradation product as suggested by the peak shoulders. The time profiles for their formation as well as for the consumption of hGH are shown in Fig. 3 .
Prior to the characterization of peak 1 and peak 2 in Fig. 2 , the chemical modifications of a complete reaction mixture were characterized by tryptic mapping (see Fig. 1 for the primary sequence of hGH and the assignment of the tryptic fragments). Most of the tryptic fragments are well separated by RP-HPLC; complimentary tryptic mapping by CXC was used to monitor the T3 fragment, which is highly positively charged and elutes closely to the solvent front during the RP-HPLC analysis. Representative tryptic maps of native and oxidized hGH are displayed in Fig. 4 for RP-HPLC and Fig. 5 for CXC. Peak assignment in the RP-HPLC chromatogram was achieved by fraction collection and off-line analysis by ESI or MALDI-TOF MS. The identities of the respective peaks together with the theoretical and measured molecular masses are displayed in Table II . The 
FIG. 2.
Representative anion exchange chromatograms of hGH at 2 (reaction at initiation) and 150 (reaction at termination) minutes of exposure to ascorbate/Cu(II)/O 2 . Reaction conditions (standard reaction conditions): air-saturated aqueous solution containing 18 M hGH, 10 M CuCl 2 , 100 M ascorbate, and 10 mM sodium phosphate buffer, pH 7.4, at 25°C. AXC conditions are as described in Table I . Table I ); x axis: reaction time, y axis: % peak area relative to peak area of initial unoxidized hGH. The solid lines through the points are included for clarity but are not computer fits.
retention behavior of the T3 fragment during CXC was confirmed by comparison to a synthetic standard.
A comparison of the chromatograms in Figs. 4 and 5 reveals that a number of fragments were modified by the ascorbate/ Cu(II)/O 2 system, but T3 and T4 constituted the predominant targets. Table II summarizes the loss of each fragment and the yields of oxidation products. Two oxidation resistant fragments, T12 and T13, were chosen as the internal standards. Each oxidation product was quantified by comparing its peak area with the original peak area of its parent fragment in the unmodified protein, assuming similar response factors.
Tryptic mapping by RP-HPLC in conjunction with off-line ESI-MS revealed several product peaks originating from T4 (labeled T4ox 1 to T4ox 3 ) with the total area of these peaks accounting for as much as 60% of the loss of T4. The major product (T4ox 3 ) had a molecular weight corresponding to MW T4 ϩ 16, implying the incorporation of an oxygen atom into T4. One minor product had MW T4 ϩ 15 (T4ox 1 ) which, considering the accuracy of our MALDI-TOF MS measurements of Ϯ 1 atomic mass unit, might in fact correspond to MW T4 ϩ 16. One additional minor product (T4ox 2 ) corresponded to MW T4 ϩ 50.
Although T3 was well separated from the other fragments by CXC (which enabled the quantification of its loss), no new product peak was observed, suggesting that the products were less positively charged and co-eluted with the other earlier eluting fragments (Fig. 5) . By RP-HPLC (Fig. 4) , T3 (peak number 1) was barely resolved from the solvent front even with initially low concentrations of acetonitrile. The MALDI-TOF mass spectrum of peak number 1 suggested that it contained T3 as an exclusive compound. During the oxidation reaction, the loss of peak number 1 was accompanied by the emergence of a later eluting peak (peak number 2 in Fig. 4 ). MALDI-TOF MS analysis of peak number 2 revealed the presence of one major component with MW T3 ϩ 16 and two minor components with MW T3 ϩ 38 and MW T3 ϩ 54. Peak number 2 is thus assigned as T3ox, the product of oxygen incorporation into T3. The two minor components likely represent the potassium adducts of T3 (MW T3 ϩ 38) and T3ox (MW T3 ϩ 54), respectively. Based on the peak areas of peak number 1 and peak number 2 in Fig. 4 it appears that T3 is nearly quantitatively converted into T3ox.
In addition to oxidation products from T3 and T4, RP-HPLC also resolved a product peak, number 11, which had identical retention time and molecular weight as the synthetic standard of the Met 14 sulfoxide variant of T2. This conversion is nearly quantitative, i.e. 10.1% loss of T2 compares to 9.7% gain of T2ox.
FIG. 4.
Reversed-phase chromatographic analysis of tryptic maps of native and oxidized (standard conditions) hGH. Top, complete chromatograms. Bottom, expanded details for retention times of t R ϭ 3-7 min and t R ϭ 43-77 min of the top chromatograms. Peak assignment, mass analysis, and oxidation yields are summarized in Table II . RP-HPLC conditions are as described in Table I .
FIG. 5.
Representative chromatograms of tryptic maps analyzed by cation exchange chromatography of native and oxidized hGH. CXC conditions are as described in Table I. The fragments T17-T18-T19 and T18-T19 suffered an approximately 10% loss which is, however, not accompanied by any detectable major product. The potential oxidation sites on these fragments are Met 170 and/or Glu
174
. The Glu 174 residue is the third component of the metal-binding site in addition to the two His residues (20) . Met 170 , although buried in the hydrophobic core, is also located close to the metal-binding site according to the crystal structure of hGH (24) . Our results (see below) will provide evidence for the formation of hydroxyl radical-like species at the metal-binding site of the protein. Both Glu (25) and Met (26 -30) are susceptible to the attack by hydroxyl radicals, yielding a variety of non-selective reaction products. We note that Met 170 could theoretically be oxidized to Met sulfoxide by two-electron oxidants such as hydrogen peroxide, but no corresponding sulfoxide variants of T18-T19 or T17-T18-T19 were experimentally observed. The observed loss of T10c 2 (chymotryptic cleavage of T10; Ser 100 -Lys 115 ) is considered an experimental artifact since both fragments T10c 1 and T10 did not show any loss induced by metal-catalyzed oxidation.
The two major oxidation peaks (peaks 1 and 2) of hGH, resolved by AXC (Fig. 2) , were purified for individual analysis by tryptic mapping. Peak 2 contained all the original fragments except T3, suggesting that this peak represented a rather homogeneous fraction of a hGH variant only modified at T3. Peak 1 suffered significant loss of T4 (about 65%) in addition to a minor loss of T3 (about 13%).
It appears that the oxidation of hGH by the ascorbate/ Cu(II)/O 2 system is rather selective to amino acid residues located on fragments T3 and T4. The behavior of the oxidized protein and peptide species during AXC and CXC suggests that the modifications occur at basic amino acid residues. Both T3 and T4 contain histidine residues, His 18 and His 21 , respectively. Theoretically those are susceptible to oxidation/hydroxylation to yield 2-oxo-histidine (2-oxo-His), characterized by a gain of 16 atomic mass units in molecular weight (19, (31) (32) (33) . Amino acid analysis of oxidized hGH revealed that only His was modified to a significant extent with a loss of 1.4 Ϯ 0.2 His residues per protein, corresponding to 47 Ϯ 7% of the total His residues. This is consistent with the observed loss of T3 and T4. Notably His 18 and His 21 are components of the metal-binding site of hGH (20) . A third His residue, His 151 , is located next to the known deamidation site of the protein and solvent accessible (21) . However, the corresponding tryptic fragment, T15, was not significantly modified by ascorbate/Cu(II)/O 2 ( Fig. 4 and Table II) .
We employed 1 H NMR to confirm the degradation of His by virtue of the characteristic chemical shifts of the imidazole C-2 protons (34, 35) . As shown in Fig. 6a , the imidazole C-2 protons of the three His residues in native hGH gave distinct chemical shifts at 7.5-8.2 ppm at pD 7.4, comparable to the published values (34, 35) . Characteristic resonances were also observed at ␦ ϭ 6.47 ppm (resonance II), representing Tyr 28 or Tyr 160 (35) , and at ␦ ϭ 6.1 ppm (resonance I), representing a presently non-assigned Tyr and/or Phe residue (34, 35) . The oxidative modification by the ascorbate/Cu(II)/O 2 system led to a significant decrease of signal intensity only for the C-2 protons of His 18 and His 21 , but not for that of His 151 (Fig. 6b) . Thus, the NMR results corroborate the findings from both the amino acid analysis and tryptic mapping. We note that the oxidation of hGH also yields a new weak resonance at 6.2 ppm. Earlier we had shown that 2-oxo-His within the peptide Gly-(2-oxo-His)- a Peak numbers are assigned in the order of the retention time as shown in Fig. 4 . Gly-Met-Gly-Gly-Gly displays a resonance at around 6.3 ppm, assigned to the C-4 proton of the 2-oxo-His residue (36) .
Thus, on the basis of NMR, amino acid analysis, tryptic mapping, and mass spectrometry, we conclude that 2-oxo-His at positions 18 and 21 constitutes a major oxidation product of hGH modified by ascorbate/Cu(II)/O 2 . Minor yields of other hydroxylated/oxidized products are observed, such as T4ox 1 (MW T4 ϩ 15) and T4ox 2 (MW T4 ϩ 50), where T4ox 2 most likely corresponds to 4,5-dihydroxy-2-oxo-His (37), but its low yield precluded further characterization by NMR.
Structural Characterization-Oxidation of hGH by the ascorbate/Cu(II)/O 2 system did not significantly affect the higher order structure of hGH. Nondenaturing size-exclusion chromatography revealed about 23% loss of the hGH monomer paralleled by some dimer formation, while denaturing size-exclusion chromatography indicated only a 4% loss in monomer content. hGH has a single tryptophan in helix II, Trp 86 , which constrains the distance between helices II and IV through a hydrogen bond with Asp 169 on helix IV (24) . The fluorescence property of Trp 86 is a good indicator of the integrity of the protein tertiary structure (38, 39) . With excitation at 298 nm, the emission spectrum of hGH was recorded between 310 and 400 nm. No significant change of the spectrum was observed for oxidized hGH. Fluorescence spectroscopic analysis also revealed no formation of dityrosine during the oxidation ( ex ϭ 325 nm, em ϭ 400 -500 nm). Far-UV circular dichroism measurements showed only minimal loss of overall ␣-helical content of the oxidized hGH. In addition, the NMR spectra of the native and oxidized hGH (Fig. 6, a and b) were largely identical besides the changes of the intensity of the histidine-related signals, confirming that the integrity of the higher order structure of hGH was maintained after the oxidation by ascorbate/Cu(II)/O 2 .
The Source of Oxygen in 2-Oxo-His
Although 2-oxo-His has been documented as a product from metal-catalyzed oxidation of His (19, (31) (32) (33) 36) , its mechanism of formation as well as the source of oxygen has never been characterized in detail. In particular the source of oxygen is critical: incorporation of oxygen from the solvent water would indicate an intermediary imidazole cation or radical cation, generated by electron transfer to any type of oxidant, followed by reaction with aqueous OH Ϫ ; in contrast, the incorporation of oxygen from molecular oxygen of air would indicate the involvement of 1 . Both fragments T3 (synthetic) and T4 (purified by RP-HPLC after tryptic digestion of native hGH) were resistant to oxidation under conditions identical to those applied to hGH (i.e. 18 M peptide, 10 M Cu(II), 100 M ascorbate in air-saturated 10 mM phosphate buffer, pH 7.4).
At constant concentrations of ascorbate and hGH, the oxidation yields were sensitive to different concentrations of Cu(II), [Cu(II)], summarized in Table III The inspection of the respective ratios peak 1/⌬ hGH and peak 2/⌬ hGH reveals a bell-shaped characteristic for peak 1/⌬ hGH with low values at 2 and 50 M Cu(II), whereas peak 2/⌬ hGH shows a steady decrease with increasing [Cu(II)]. These differences are likely the result of different kinetics for the oxidation of His 18 , represented by peak 2, and His 21 , the major oxidized amino acid of peak 1. It appears that His 18 represents an early target of hGH, followed by His 21 and, eventually, some other minor targets such as Met 14 . The oxidation of hGH (18 M hGH, 10 M Cu(II), 100 M ascorbate in air-saturated 10 mM phosphate buffer, pH 7.4) was completely inhibited by the addition of 15 M EDTA. However, Zn(II) (added as ZnCl 2 ) was unable to inhibit the oxidation of hGH until the ratio of [Zn(II)]:[Cu(II)] was higher than 80:1. This result suggests a strong binding of Cu(II) to the metalbinding site of hGH and is particularly interesting with regard to the fact that Zn(II) regulates storage and biological activity of hGH under physiological conditions (20, 40) .
Characterization of Hydrogen Peroxide and Cu(I) as Important Intermediates
Hydrogen Peroxide-The oxidation of hGH was inhibited by Ͼ50 units/ml native catalase (18 M hGH, 10 M Cu(II), 100 M ascorbate in air-saturated 10 mM phosphate buffer, pH 7.4) but not by heat-inactivated catalase, indicating that freely diffusable hydrogen peroxide plays an important role during the reaction. Cu,Zn-superoxide dismutase (at 200 units/ml) had no effect on the final yields of hGH oxidation but slowed down the reaction kinetics.
Cu(I)-Three vials (I-III) with each containing an N 2 -saturated solution of 18 M hGH and 15 M Cu(II) in 10 mM phosphate buffer, pH 7.4, were incubated under N 2 for 20 min with 7.5 M ascorbate, i.e. with a ratio of [ascorbate]:[Cu(II)] ϭ 1:2 to promote a stoichiometric formation of Cu(I). Subsequently, to vial I a final concentration of 100 M EDTA (separately saturated with N 2 ) was added under N 2 , vial II was opened and exposed to air, and to vial III a final concentration of 100 M hydrogen peroxide (H 2 O 2 ) (separately saturated with N 2 ) was added under N 2 . Analysis of the reaction mixture of vial I by AXC revealed that hGH had not been oxidized during the 20-min incubation (before the addition of EDTA), whereas analysis by capillary electrophoresis with electrochemical detection revealed that the reduced form of ascorbate had been completely consumed. Analysis of the reaction mixtures of vials II and III revealed that hGH had been oxidized, with higher yields in vial III, where the product stoichiometries were identical to those obtained during the oxidation of hGH by the standard system in air-saturated solutions, i.e. showed predominant oxidation of T3 and T4. In a separate experiment we added a final concentration of 100 M H 2 O 2 aerobically to a solution containing 18 M hGH, 10 M Cu(II), and 10 mM phosphate buffer, pH 7.4. Here, no oxidation of hGH was observed over a time of 150 min. These results imply the anaerobic reduction of Cu(II) to Cu(I) via net reactions 1 and 2, where AH Ϫ , A . , and A denote ascorbate, the ascorbyl radical anion, and dehydroascorbic acid, respectively.
Subsequently, upon exposure to oxygen or H 2 O 2 , Cu(I) promotes the formation of an oxidizing species ultimately responsible for the oxidation of His in T3 and T4, respectively (see "Discussion"). Since aqueous Cu(I) is thermodynamically unstable with respect to disproportionation (reaction 3) (41, 42) we expect that all Cu(I), present after the complete anaerobic consumption of ascorbate, is ligated by the protein.
Spectroscopic experiments were undertaken to test this hypothesis. An N 2 -saturated aqueous (D 2 O) solution containing 10 mM phosphate buffer, pD 7.4, 200 M hGH, and 95 M CuCl 2 was reacted with 50 M ascorbate and subsequently transferred under N 2 in a gas tight syringe into an NMR tube (separately saturated with N 2 ). This mixture essentially contained hGH, hGH-Cu(I), and oxidized ascorbate (see above). The mixture was allowed to stand for 24 h (to promote H/D exchange) before the NMR spectrum, displayed in Fig. 6c , was recorded. The comparison of (Fig. 6d) shows several significant differences as compared with the spectra of the hGH-Cu(I) complex (Fig. 6c ) and native hGH (Fig. 6a) . The resonances of His 18 and His 21 at ␦ ϭ 8.29 ppm and ␦ ϭ 7.58 ppm, present for native hGH and hGH-Cu(I), (Fig. 2) .
are essentially absent in the presence of Cu(II). Instead of a sharp resonance for His
151
, Fig. 6d displays a relatively weak, broad, and noisy signal around ␦ ϭ 7.8 -7.9 ppm. Small resonances on both sides of the large peak at ␦ ϭ 6.8 ppm, present for native hGH and hGH-Cu(I), are nearly absent in the presence of Cu(II). The intensity of the resonance at ␦ ϭ 7.4 ppm (Fig. 6, a and c) is significantly reduced in the presence of Cu(II). (iii) The 1 H NMR spectrum of an aerobic aqueous (D 2 O) solution containing 10 mM phosphate buffer, pD 7.4. 400 M hGH and 400 M Zn(II) is displayed in Fig. 6e . Some features of the spectrum are similar to those observed in the presence of Cu(II), namely the absence of the resonances for His 18 and His 21 at ␦ ϭ 8.29 ppm and ␦ ϭ 7.58 ppm, respectively, the absence of the small resonances on both sides of the peak at ␦ ϭ 7.4 ppm, and the broad, although more intense, resonance around ␦ ϭ 7.9 ppm. Binding of Zn(II) to the metal-binding site of hGH is well established (K d Ϸ 1 ϫ 10 Ϫ6 M) (20) . The similar effects of Zn(II) and Cu(II) on the 1 H NMR spectrum of hGH may indicate that also a fraction of Cu(II) binds to the metalbinding site. However, the physical rationale for the disappearance of the resonances of His 18 and His 21 may be different for both metals: first, the geometry of the Zn(II) and the Cu(II) complex may be different resulting in different ligand fields. Second, due to the paramagnetic nature of Cu(II), the disappearance of the His resonances is likely caused by extensive peak broadening. We note, however, that in the presence of Cu(II) particularly the resonances at ␦ Յ 6.8 ppm (Fig. 6d) are clearly visible and their peak shape comparable to those of native hGH (Fig. 6a) , indicating that peak broadening by the paramagnetic Cu(II) seems to be restricted to amino acid side chains directly involved in the binding of Cu(II) and not related to an overall field effect. This feature may be taken as an additional evidence for the binding of Cu(II) to the metalbinding site of hGH. The NMR results can be summarized as follows. The incubation of hGH with Cu(II) results in spectral changes some of which are similar to those induced by the binding of Zn(II) to the metal-binding site, suggesting that a fraction of Cu(II) also binds to the metal-binding site of hGH. The spectrum of the hGH-Cu(II) system is distinctly different from the spectrum of the hGH-Cu(I) system which, nevertheless, differs from the spectrum of native hGH. The fact that some of the amide resonances of the hGH-Cu(I) complex appear to be more resistant to H/D exchange than those of native hGH suggests a more rigid structure of hGH-Cu(I). This could be rationalized by the binding of Cu(I) to the metal-binding site of hGH, supported by the observation that the exposure of the hGH-Cu(I) to O 2 or hydrogen peroxide (anaerobic) resulted in the site-specific oxidation of hGH at the His residues of T3 and T4, i.e. within the metal-binding site.
The Effect of 1-Propanol
It was reported that 1-propanol induces a small change of the tertiary structure of hGH to a molten globular state (39). When we exposed hGH to the ascorbate/Cu(II)/O 2 system in mixtures of (i) methanol and water, and (ii) 1-propanol and water, there was no effect of methanol up to a content of 40% (v/v). However, the extent of oxidation followed a sigmoidal behavior with no significant change between 0 and 20% 1-propanol (v/v), but about 80% inhibition at 28% 1-propanol (Fig. 7) . This significant change in inhibition within a narrow range of 1-propanol content suggests the involvement of a structural transition of the protein. Indeed, the sigmoidal inhibition curve of hGH oxidation approximately paralleled the variation of protein tertiary structure characterized by fluorescence spectroscopy (39) . On the other hand, the lack of any effect of comparable concentrations of methanol shows that it was not merely the presence of an alcoholic functional group in the solvent which caused the observed protection. Fig. 6f shows the 1 H NMR spectrum of native hGH in D 2 O in the presence of 40% 1-propanol-d 7 (CD 3 CD 2 CD 2 OH) (v/v; pD ϭ 7.4, measured before the addition of 1-propanol-d 7 ) . The three resonances in the range ␦ ϭ 7.6 -7.8 ppm were assigned to the three His residues in the following way. A sample of hGH was exposed to ascorbate/Cu(II)/O 2 in the absence of 1-propanol to oxidize His 18 and His 21 . Oxidized hGH is characterized through the lack of the characteristic resonances of His 18 and His 21 in the NMR spectrum (Fig. 6b) . Subsequently, the sample containing oxidized hGH was lyophilized and redissolved in aqueous (D 2 O) solution, pD 7.4, containing 40% (v/v) 1-propanol-d 7 . The NMR spectrum of this sample was identical to Fig. 6f except that it did not show the two resonances in the region ␦ ϭ 7.60 -7.65 ppm. Therefore, in Fig. 6f the two resonances around ␦ ϭ 7.60 -7.65 ppm can be assigned to His 18 and His 21 in some order, whereas the resonance around 7.8 ppm can be assigned to His 151 , as labeled. In particular the resonance of His 18 is significantly shifted in the presence of 40% (v/v) 1-propanol-d 7 as compared with native hGH in the absence of 1-propanol. A nearly similar upfield shift (to ␦ ϭ 7.64 ppm) of the His 18 resonance is achieved in the absence of 1-propanol by an increase of the pD to pD 8.5, shown in the NMR spectrum in Fig.  6g where the broad peak around ␦ ϭ 7.65 ppm contains the resonances of both His 18 and His 151 (35) . At pD 8.5 all His residues of hGH present their imidazole side chains in the neutral form (35) and the salt bridge between His 18 of helix I and Asp 171 of helix IV is lost, resulting in a change of the relative positions of helix I and helix IV (35) . By analogy this suggests that 1-propanol perturbs the interactions of helix I and helix IV through the weakening of hydrophobic interactions and, therefore, perturbs the metal-binding site. This hypothesis derives further support from the 1 H NMR spectra of Fig. 6 , a, f, and g, in the 6.0 -6.6 ppm region. Native hGH shows resonances I and II in the absence of 1-propanol at pD 7.4 ( Fig.  6a ) and pD 8.5 (Fig. 6g) , whereas both resonances are absent in the presence of 40% 1-propanol at pD 7.4 (Fig. 6f) . Both Tyr 28 and Tyr 160 , represented by resonance II, are located in the contact area of helices I and IV, respectively (35) . Resonance I represents a presently unidentified Tyr or Phe residue (34, 35) several of which are located in the contact area of helices I and IV such as, e.g. Phe 25 , Phe 31 , and Phe 166 (35) . At pH 8.5 in the absence of 1-propanol (18 M hGH, 10 M Cu(II), 100 M ascorbate in air-saturated 10 mM phosphate buffer), hGH was oxidized to an extent comparable to that at pH 7.4 in the absence of 1-propanol (data not shown). Thus, the mere lack of a salt bridge between His 18 and Asp 171 (see above) is not sufficient for an inhibition of oxidation, suggesting that the protection exerted by 1-propanol requires (i) additional structural modifications of the metal-binding site and/or (ii) other additional parameters. If 1-propanol perturbs the metalbinding site by weakening hydrophobic interactions between helix I and helix IV, 1-propanol has to insert between the helices where it may locate close to the perturbed metal-binding site. A close proximity would enable 1-propanol to scavenge ROS generated at the metal. To test this possibility we performed the oxidation of hGH (standard conditions) in the additional presence of (i) 30% (v/v) 1-propanol-h 7 or (ii) 30% (v/v) 1-propanol-d 7 (CD 3 CD 2 CD 2 OH). A content of 30% (v/v) 1-propanol-h 7 exerted maximum protection with about 77 Ϯ 7% native hGH left after oxidation (Fig. 7) . In contrast, the inhibition by 30% (v/v) 1-propanol-d 7 was significantly less efficient, with only 39 Ϯ 5% native hGH left after oxidation (data not shown). This product isotope effect, expressed as [residual hGH] 1-propanol-h7 /[residual hGH] 1-propanol-d7 ϭ 1.95, likely reflects a kinetic isotope effect with 1-propanol-d 7 being a less efficient scavenger of ROS. Thus, part of the inhibition by 1-propanol may be due to the scavenging of ROS, generated within a perturbed metal-binding site, and the product isotope effect may serve as a basis for mechanistic considerations.
DISCUSSION
The (43) .
The 
We note that ascorbate will not stay bound at the Cu(I) center within the metal-binding site, i.e. at [hGH-Cu(I)] mbs . This conclusion is based on the fact that no reduced ascorbate was detectable in anaerobic solutions of hGH-Cu(I) subsequent to the addition of EDTA (see above). By 1 H NMR spectroscopy we have obtained some evidence for the existence of an hGH-Cu(I) complex although the spectroscopic data alone do not allow us to identify this complex as [hGH-Cu(I)] mbs . This may, however, be concluded from the fact that the anaerobic reaction of a hGH-Cu(I) system with hydrogen peroxide resulted in the specific oxidation of His 18 There was a marked reduction of hGH oxidation in the presence of additional Ն28% (v/v) 1-propanol, i.e. under conditions where hGH undergoes a structural transition to a molten globular state. The 1 H NMR spectrum of hGH recorded in aqueous solution containing 40% (v/v) 1-propanol suggests that the presence of 1-propanol affects the interactions between helix I and helix IV of hGH which construct the metal-binding site. However, even at a high content of 1-propanol there is a residual level (about 23%) of metal-catalyzed oxidation of hGH, suggesting that even the molten globular state of hGH provides a chelating entity sufficient for some binding of the metal. This observation leads to the question whether the basis of the inhibitory role of 1-propanol is only the perturbation of the metal-binding site or the combination of such perturbation and additional factors. The experimental product isotope effect of [residual hGH] 1-propanol-h7 /[residual hGH] 1-propanol-d7 ϭ 1.95 likely reflects a kinetic isotope effect where an oxidizing species reacts less efficiently with the C-D bond of 1-propanol-d 7 as compared with the C-H bond of 1-propanol-h 7 . Hence, there is a more efficient protection by 1-propanol-h 7 . The fact that a product isotope effect is measurable may indicate that the perturbation by 1-propanol is through insertion between the hydrophobic sites of helix I and helix IV bringing 1-propanol sufficiently close to the yet perturbed metal-binding site to scavenge reactive oxygen species. Three experimental facts would support an assignment that this reactive species is either a hydroxyl radical or a metal-bound equivalent, a complexed hydroxyl radical: (i) the anaerobic reaction of hydrogen peroxide with a hGH-Cu(I) complex, most likely [hGHCu(I)] mbs , is expected to proceed according to Equations 12 and 13 (44 (ii) The most reactive C-H bonds of 1-propanol are the respective C ␣ -H bonds (45) . Pulse radiolytic studies have shown that the primary kinetic isotope effect for the reaction of the hydroxyl radical with the C ␣ -H and the C ␣ -D bonds of methanol-h 3 and methanol-d 3 , respectively, is on the order of k H /k D ϭ 2.25 (46), i.e. close to our experimentally obtained product isotope effect for 1-propanol. (iii) The oxygen incorporated into the product, 2-oxo-His, originated from molecular oxygen. On the basis of Equations 4 -8, 12, and 13 the oxygen of the hydroxyl radical species will originate from molecular oxygen. A simple mechanism for the direct incorporation of the hydroxyl radical oxygen into 2-oxo-His is displayed in the Scheme 1 (reactions 14 -16).
We note that the formation of 2-oxo-His via the displayed pathway requires the net addition of HO ⅐ at C-2 of the imidazole ring whereas ESR investigations on the addition of radiation chemically produced freely diffusable hydroxyl radicals to imidazole derivatives not complexed to transition metals have provided evidence for the addition of HO ⅐ at C-4 and C-5 (47) . A preferred net addition of HO ⅐ to C-2 of His during the metalcatalyzed oxidation of hGH could be the result of metal-binding, the geometry of the metal-binding site, and the fact that a complexed rather than a free hydroxyl radical is the actual reactive oxygen species. In our tryptic map of hGH we identified low quantities of other oxidation products of His (T4 ox1 and T4 ox2 ) most likely representing products of the net addition of HO ⅐ at other positions of the imidazole ring such as C-4 and C-5. In this regard we note that the generation of free and/or complexed hydroxyl radicals has also been proposed for the reaction of hydrogen peroxide with Cu(I) superoxide dismutase (44, 48, 49) where 2-oxo-His was a major product of the modification of His 118 (32) located at the metal-binding site. Biological Significance-The binding of hGH to the hGH receptor is largely Zn 2ϩ -independent whereas binding to the human prolactin (hPRL) receptor requires Zn 2ϩ and an intact metal-binding site of hGH (14) . When each of the three amino acids involved in metal binding, i.e. His 18 , His 21 , and Glu 174 , was individually mutated to Ala, there was a 3,000 -12,000-fold decrease of affinity of the respective hGH mutants to a recombinant protein containing the hGH-binding sequence of the hPRL receptor (hPRL binding protein, hPRLbp) (14) . In contrast, these hGH mutants showed less significant change of binding to a recombinant protein containing the hGH-binding sequence of the hGH receptor (hGH-binding protein) (14) . Thus, it appears that the chemical modification of a metalbinding side chain to a non-metal-binding side chain of only one amino acid of the metal-binding site is sufficient for the change of the affinity to hPRL-binding protein. We can reasonably assume that the 2-oxo tautomer of 2-oxo-His has a significantly lower affinity for metals as compared with a native imidazole ring due to the lack of the pyridine nitrogen. Therefore, we expect that the modification of His to 2-oxo-His in hGH may result in a decrease of the affinity to hPRLbp but not to hGHbinding protein, but this remains to be demonstrated in future experiments.
